Company Search:
Advanced Search
Sponsored Links
E-Therapeutics Plc Company Snapshot
E-Therapeutics Plc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares E-Therapeutics Plc with three other companies in this sector in the United Kingdom: Reneuron Group PLC (2009 sales of £93,000.00 [US$129,888.45 ] of which 100% was Cell-Based Therapies), Valirx Plc (£29,326.00 [US$40,958.16 ] of which 100% was Drug Development), and Sareum Holdings PLC (£31,600.00 [US$44,134.14 ] of which 100% was Therapeutic Drugs).

Sales Analysis.
  Stock Performance Chart for E-Therapeutics Plc
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 8.75p
(Figures in Pounds Sterling)
1 Week 0.0%   13 Weeks 0.0%  
4 Weeks -1.4%   52 Weeks 6.1%  
E-Therapeutics Plc Key Data:
  Ticker: ETX Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2009 Sales 67,000
(Year Ending Jan 2010).
Employees: 24
  Currency: Pounds Sterling Market Cap: 23,496,451
  Fiscal Yr Ends: January Shares Outstanding: 268,530,866
  Share Type: Ordinary Closely Held Shares: 71,958,259
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.